These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39258961)

  • 21. A new data analysis approach for measuring longitudinal changes of metabolism in cognitively normal elderly adults.
    Shokouhi S; Riddle WR; Kang H
    Clin Interv Aging; 2017; 12():2123-2130. PubMed ID: 29276381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associating Type 2 Diabetes Risk Factor Genes and FDG-PET Brain Metabolism in Normal Aging and Alzheimer's Disease.
    Nugent S; Potvin O; Cunnane SC; Chen TH; Duchesne S
    Front Aging Neurosci; 2020; 12():580633. PubMed ID: 33192474
    [No Abstract]   [Full Text] [Related]  

  • 23. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.
    Ossenkoppele R; Schonhaut DR; Schöll M; Lockhart SN; Ayakta N; Baker SL; O'Neil JP; Janabi M; Lazaris A; Cantwell A; Vogel J; Santos M; Miller ZA; Bettcher BM; Vossel KA; Kramer JH; Gorno-Tempini ML; Miller BL; Jagust WJ; Rabinovici GD
    Brain; 2016 May; 139(Pt 5):1551-67. PubMed ID: 26962052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selection of the optimal intensity normalization region for FDG-PET studies of normal aging and Alzheimer's disease.
    Nugent S; Croteau E; Potvin O; Castellano CA; Dieumegarde L; Cunnane SC; Duchesne S
    Sci Rep; 2020 Jun; 10(1):9261. PubMed ID: 32518360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative
    Zhao Q; Liu M; Ha L; Zhou Y;
    Front Neurol; 2019; 10():486. PubMed ID: 31156534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of a multi-domain intervention on cerebral glucose metabolism: analysis from the randomized ancillary FDG PET MAPT trial.
    Delrieu J; Voisin T; Saint-Aubert L; Carrie I; Cantet C; Vellas B; Payoux P; Andrieu S
    Alzheimers Res Ther; 2020 Oct; 12(1):134. PubMed ID: 33076983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function.
    Dowling NM; Johnson SC; Gleason CE; Jagust WJ;
    Neuroimage; 2015 Jan; 105():357-68. PubMed ID: 25450107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute effects of two different work-to-rest ratio of high-intensity interval training on brain-derived neurotrophic factor in untrained young men.
    Zhao K; Hu Z; Wang T; Tian L; Wang M; Liu R; Zuo C; Jihua W
    Front Physiol; 2022; 13():988773. PubMed ID: 36160866
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of early-phase [
    Daerr S; Brendel M; Zach C; Mille E; Schilling D; Zacherl MJ; Bürger K; Danek A; Pogarell O; Schildan A; Patt M; Barthel H; Sabri O; Bartenstein P; Rominger A
    Neuroimage Clin; 2017; 14():77-86. PubMed ID: 28138429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between astrocyte reactivity, using novel
    Livingston NR; Calsolaro V; Hinz R; Nowell J; Raza S; Gentleman S; Tyacke RJ; Myers J; Venkataraman AV; Perneczky R; Gunn RN; Rabiner EA; Parker CA; Murphy PS; Wren PB; Nutt DJ; Matthews PM; Edison P
    Mol Psychiatry; 2022 Apr; 27(4):2019-2029. PubMed ID: 35125495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mediating effect of
    Wang B; Cui C; Chen Y; Liang Z
    Front Aging Neurosci; 2024; 16():1328143. PubMed ID: 38511197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain Glucose Metabolism, Cognition, and Cardiorespiratory Fitness Following Exercise Training in Adults at Risk for Alzheimer's Disease.
    Gaitán JM; Boots EA; Dougherty RJ; Oh JM; Ma Y; Edwards DF; Christian BT; Cook DB; Okonkwo OC
    Brain Plast; 2019 Dec; 5(1):83-95. PubMed ID: 31970062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Randomized, Double-Blind, Phase 2 Study of the Effects of the Vaccine Vanutide Cridificar with QS-21 Adjuvant on Immunogenicity, Safety and Amyloid Imaging in Patients with Mild to Moderate Alzheimer's Disease.
    Ketter N; Liu E; Di J; Honig LS; Lu M; Novak G; Werth J; LePrince Leterme G; Shadman A; Brashear HR
    J Prev Alzheimers Dis; 2016; 3(4):192-201. PubMed ID: 29199321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebral Metabolic Signature of Chronic Benzodiazepine Use in Nondemented Older Adults: An FDG-PET Study in the MEMENTO Cohort.
    Gallet Q; Bouteloup V; Locatelli M; Habert MO; Chupin M; Campion JY; Michels PE; Delrieu J; Lebouvier T; Balageas AC; Surget A; Belzung C; Arlicot N; Ribeiro MS; Gissot V; El-Hage W; Camus V; Gohier B; Desmidt T;
    Am J Geriatr Psychiatry; 2024 Jun; 32(6):665-677. PubMed ID: 37973486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Principal-Component Analysis-Based Measures of PET Data Closely Reflect Neuropathologic Staging Schemes.
    Blazhenets G; Frings L; Sörensen A; Meyer PT;
    J Nucl Med; 2021 Jun; 62(6):855-860. PubMed ID: 33097630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of aerobic exercise on brain metabolism and grey matter volume in older adults: results of the randomised controlled SMART trial.
    Matura S; Fleckenstein J; Deichmann R; Engeroff T; Füzéki E; Hattingen E; Hellweg R; Lienerth B; Pilatus U; Schwarz S; Tesky VA; Vogt L; Banzer W; Pantel J
    Transl Psychiatry; 2017 Jul; 7(7):e1172. PubMed ID: 28934191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparability of [
    Rodriguez-Vieitez E; Leuzy A; Chiotis K; Saint-Aubert L; Wall A; Nordberg A
    J Cereb Blood Flow Metab; 2017 Feb; 37(2):740-749. PubMed ID: 27107028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of Brain Glucose Metabolism Following Cardiac Arrest by [
    Zhang HJ; Mitchell S; Fang YH; Tsai HM; Piao L; Ousta A; Leoni L; Chen CT; Sharp WW
    Neurocrit Care; 2021 Feb; 34(1):64-72. PubMed ID: 32358767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain alterations in the early Alzheimer's continuum with amyloid-β, tau, glial and neurodegeneration CSF markers.
    Salvadó G; Shekari M; Falcon C; Operto G; Milà-Alomà M; Sánchez-Benavides G; Cacciaglia R; Arenaza-Urquijo E; Niñerola-Baizán A; Perissinotti A; Minguillon C; Fauria K; Kollmorgen G; Suridjan I; Molinuevo JL; Zetterberg H; Blennow K; Suárez-Calvet M; Gispert JD;
    Brain Commun; 2022; 4(3):fcac134. PubMed ID: 35702732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
    Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.